Monopar Therapeutics Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-04-01: Form 10-K/A; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value · MNPR · NASDAQ.
- 2026-03-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value · MNPR · NASDAQ.
- 2025-03-31: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value · MNPR · NASDAQ.
- 2024-11-08: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2026-04-01 | 10-K/A | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2026-03-27 | 10-K | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2025-03-31 | 10-K | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2024-11-08 | 10-Q | Emerging growth company | Yes |
| 2024-08-09 | 10-Q | Emerging growth company | Yes |
| 2024-05-09 | 10-Q | Emerging growth company | Yes |
| 2024-03-28 | 10-K | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2024-03-28 | 10-K | Emerging growth company | Yes |
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
| 2023-08-10 | 10-Q | Emerging growth company | Yes |
| 2023-05-11 | 10-Q | Emerging growth company | Yes |
| 2023-03-23 | 10-K | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2023-03-23 | 10-K | Emerging growth company | Yes |
| 2022-11-10 | 10-Q | Emerging growth company | Yes |
| 2022-08-11 | 10-Q | Emerging growth company | Yes |
| 2022-05-12 | 10-Q | Emerging growth company | Yes |
| 2022-03-24 | 10-K | Stock registered under Section 12(b) | Common stock, $0.001 par value · MNPR · NASDAQ |
| 2022-03-24 | 10-K | Emerging growth company | Yes |
| 2021-11-12 | 10-Q | Emerging growth company | Yes |
| 2021-08-12 | 10-Q | Emerging growth company | Yes |
| 2021-05-13 | 10-Q | Emerging growth company | Yes |
| 2021-03-25 | 10-K | Emerging growth company | Yes |
| 2021-03-25 | 10-K | Current in its reporting | No |
| 2020-11-12 | 10-Q | Emerging growth company | Yes |
| 2020-08-06 | 10-Q | Emerging growth company | Yes |
| 2020-05-07 | 10-Q | Emerging growth company | Yes |
| 2020-03-27 | 10-K | Emerging growth company | Yes |
| 2020-03-27 | 10-K | Current in its reporting | No |
| 2019-11-12 | 10-Q | Emerging growth company | Yes |
| 2019-08-08 | 10-Q | Emerging growth company | Yes |
| 2019-05-10 | 10-Q | Emerging growth company | Yes |
| 2019-02-26 | 10-K | Emerging growth company | Yes |
| 2019-02-26 | 10-K | Current in its reporting | No |
| 2018-11-09 | 10-Q | Emerging growth company | Yes |
| 2018-08-09 | 10-Q | Current in its reporting | No |
| 2018-05-11 | 10-Q | Current in its reporting | No |
| 2018-03-26 | 10-K | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |